SCHEMBL4138083

SCHEMBL4138083

O=c1[nH]c2ccccc2n1-c1ccc(O)cc1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 6/20 1.00
▸ AURKA O14965 5/20 0.51
▸ PLA2G10 O15496 1/20 0.49
▸ MGAM O43451 1/20 0.49
▸ PLA2G2A P14555 1/20 0.49
▸ PLA2G5 P39877 1/20 0.49
▸ PLA2G12A Q9BZM1 1/20 0.49
▸ DAO P14920 1/20 0.47
▸ AKT2 P31751 1/20 0.45
▸ CLK2 P49760 1/20 0.45
▸ DYRK1A Q13627 1/20 0.45
▸ CLK4 Q9HAZ1 1/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ HTT P42858 1/20 0.45
▸ MAPT P10636 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9119078 0.84 HSP90AA1 (0.72) HSP90AA1AURKADAOKDM4EMAPT
SCHEMBL5431254 0.79 HSP90AA1 (0.71) HSP90AA1AURKADAOAKT2CLK2
SCHEMBL5434927 0.79 HSP90AA1 (1.00) HSP90AA1DAOAKT2CLK2DYRK1A
SCHEMBL5437772 0.78 HSP90AA1 (0.69) HSP90AA1AURKADAOAKT2CLK2
SCHEMBL5440403 0.78 HSP90AA1 (0.69) HSP90AA1AURKADAOAKT2CLK2
SCHEMBL5440578 0.78 HSP90AA1 (0.74) HSP90AA1AURKAAKT2CLK2DYRK1A
SCHEMBL9559146 0.77 HSP90AA1 (0.62) HSP90AA1AURKADAOKDM4EMAPT
SCHEMBL9119941 0.77 HSP90AA1 (0.75) HSP90AA1AURKADAOAKT2CLK2
SCHEMBL5439923 0.76 HSP90AA1 (0.66) HSP90AA1AURKADAOAKT2CLK2
SCHEMBL5447991 0.76 HSP90AA1 (0.66) HSP90AA1AURKADAOAKT2CLK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090069341-A1 INHIBITORS OF HSP90 CHENE PATRICK 2009-03-12 — — US disclosed
US-20070105862-A1 Heat-shock protein binders ABBOTT LABORATORIES 2007-05-10 — — US disclosed
EP-1776110-A1 INHIBITORS OF HSP90 Novartis AG (CH) 2007-04-25 — — EP disclosed
WO-2006010594-A1 INHIBITORS OF HSP90 NOVARTIS AG (CH) 2006-02-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069341-A1 INHIBITORS OF HSP90 HSP90AB1, HSP90B1, HSP90AA1 HSP90AA1 3/4885AURKA 977/4885PLA2G10 4514/4885
US-20070105862-A1 Heat-shock protein binders HSP90AB1, HSP90AB2P, HSP90B1 HSP90AA1 5/4885AURKA 3202/4885PLA2G10 4115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback